Fig. 3.
Overall survival from the time of inclusion in the LNH-87 trial. Comparison of patients with ALCL of B-cell type (n = 56) and patients with nonanaplastic diffuse large-cell lymphoma of B-cell type (n = 1,368); P = .037.
Overall survival from the time of inclusion in the LNH-87 trial. Comparison of patients with ALCL of B-cell type (n = 56) and patients with nonanaplastic diffuse large-cell lymphoma of B-cell type (n = 1,368); P = .037.
